We use some essential cookies to make this website work.
We’d like to set additional cookies to understand how you use GOV.UK, remember your settings and improve government services.
We also use cookies set by other sites to help us deliver content from their services.
You have accepted additional cookies. You can change your cookie settings at any time.
You have rejected additional cookies. You can change your cookie settings at any time.
Departments, agencies and public bodies
News stories, speeches, letters and notices
Detailed guidance, regulations and rules
Reports, analysis and official statistics
Consultations and strategy
Data, Freedom of Information releases and corporate reports
The MHRA has today, 26 November 2025, approved inavolisib (Itovebi) for the treatment of adults with a type of breast cancer called HR-positive
Vaccination is one of the most effective and safest ways to protect against many serious infectious diseases
New government funding will help make the boldest ideas in UK life sciences a reality.
International collaboration establishes new quality standards to improve reliability of gut health studies – improving accuracy to provide better diagnosis and treatment.
As part of #MedSafetyWeek, the MHRA’s Chief Safety Officer reflects in The Pharmacist on the vital role pharmacists play in keeping medicines and medical devices safe.
The Medicines and Healthcare products Regulatory Agency (MHRA) has approved Siiltibcy
Professor Jacob George has been appointed as the first Chief Medical and Scientific Officer for the Medicines and Healthcare products Regulatory Agency (MHRA).…
Professor Henrietta Hughes reflects on how MHRA strategy must prioritise patient safety via listening to lived experiences, fostering collaboration & innovation.
The tenth annual #MedSafetyWeek brings together more than 130 medicines regulators and health organisations across 117 countries to encourage people to report suspected side effects from medicines and device incidents.
New paper sets out UK regulator's intentions to overhaul rulebook for rare disease therapies in UK
As with any medicine, the MHRA will keep the safety and effectiveness of concizumab under close review.
MHRA strikes massive blow to organised criminal gang in world’s biggest illegal weight loss jabs raid.
The government has announced it is slashing the red tape that holds back groundbreaking innovations from coming to market.
The MHRA leads three new government-backed projects using AI-driven approaches to make medicines safer and bring treatments to patients more quickly.
A new blueprint for AI regulation is being announced by the Technology Secretary today (Tuesday 21 October) to help drive innovation and growth.
Seven emerging AI healthcare technologies have been selected for the second phase of the MHRA’s AI Airlock programme.
Developers work with the NHS, the medicines regulator and the UK health technology assessment bodies from the early stages of clinical development, as part of the Innovative Licensing and Access Pathway.
The MHRA produces over 95 per cent of the World Health Organization’s (WHO) biological standards.
The MHRA’s Interim Executive Director of Science and Research writes in The British Medical Journal on the approval of the UK’s first new UTI antibiotic in nearly 30 years, and the wider challenge of tackling antibiotic resi…
Aligned pathway will streamline decisions on licensing and value for medicines, helping patients to benefit from them sooner.
Don’t include personal or financial information like your National Insurance number or credit card details.
To help us improve GOV.UK, we’d like to know more about your visit today. Please fill in this survey (opens in a new tab and requires JavaScript).